Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Haematologica|January 25, 2012
Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Haematologica|November 13, 2010
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Hemasphere|July 16, 2024
Recommendations for diagnosis, treatment, and prevention of iron deficiency and iron deficiency anemiaAchille Iolascon, Immacolata Andolfo, Roberta Russo, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 9, 2022
A national study of antibiotic use in Greek pediatric hematology oncology and bone marrow transplant unitsElpis Mantadakis, Ioannis Kopsidas, Susan Coffin, et al.
Blood|December 10, 2009
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemiaDudley J Pennell, John B Porter, Maria Domenica Cappellini, et al.
Blood Advances|August 28, 2025
Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND studyAli T Taher, Vip Viprakasit, Antonis Kattamis, et al.
European Journal of Haematology|May 23, 2018
Targeted next generation sequencing for the diagnosis of patients with rare congenital anemiasNoa Shefer Averbuch, Orna Steinberg-Shemer, Orly Dgany, et al.
Acta Bio-Medica : Atenei Parmensis|July 2, 2021
The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A surveyVincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, et al.
British Journal of Haematology|April 26, 2017
Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver diseaseEmmanouil Sinakos, Dimitrios Kountouras, John Koskinas, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 15, 2020
A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A ExperienceVincenzo De Sanctis, Ashraf T Soliman, Shahina Daar, et al.
Pageof 17